Cas:1121589-53-4 3-[(2-Fluorobenzyl)oxy]azetidine hydrochloride manufacturer & supplier

We serve Chemical Name:3-[(2-Fluorobenzyl)oxy]azetidine hydrochloride CAS:1121589-53-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-[(2-Fluorobenzyl)oxy]azetidine hydrochloride

Chemical Name:3-[(2-Fluorobenzyl)oxy]azetidine hydrochloride
CAS.NO:1121589-53-4
Synonyms:3-[(2-Fluorobenzyl)oxy]azetidine hydrochloride
Molecular Formula:C10H13ClFNO
Molecular Weight:217.66800
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:21.26000
Exact Mass:217.06700
LogP:2.44490

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-[(2-Fluorobenzyl)oxy]azetidine hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-[(2-Fluorobenzyl)oxy]azetidine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-[(2-Fluorobenzyl)oxy]azetidine hydrochloride Use and application,3-[(2-Fluorobenzyl)oxy]azetidine hydrochloride technical grade,usp/ep/jp grade.


Related News: Onyx Scientific, a small molecule API contract development and manufacturing organization (CDMO) has received a commercial API license for its UK facility. (3S)-3-amino-4-(4-hydroxyphenyl)butanoic acid,hydrochloride manufacturers EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. Ethyl 2-formyl-1,3-oxazole-4-carboxylate suppliers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” tert-butyl 4-(1H-pyrazol-1-yl)piperidine-1-carboxylate vendor & factory.